Commentary: Post-Transplantation Cyclophosphamide Uniquely Restrains Alloreactive CD4+ T-Cell Proliferation and Differentiation After Murine MHC-Haploidentical Hematopoietic Cell Transplantation
- PMID: 35493453
- PMCID: PMC9046566
- DOI: 10.3389/fimmu.2022.887648
Commentary: Post-Transplantation Cyclophosphamide Uniquely Restrains Alloreactive CD4+ T-Cell Proliferation and Differentiation After Murine MHC-Haploidentical Hematopoietic Cell Transplantation
Keywords: chemotherapy; graft (regulation); graft versus host disease (GVHD); haploidentical hematopoietic stem cell transplantation; murine (mouse).
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Comment on
-
Post-Transplantation Cyclophosphamide Uniquely Restrains Alloreactive CD4+ T-Cell Proliferation and Differentiation After Murine MHC-Haploidentical Hematopoietic Cell Transplantation.Front Immunol. 2022 Feb 15;13:796349. doi: 10.3389/fimmu.2022.796349. eCollection 2022. Front Immunol. 2022. PMID: 35242129 Free PMC article.
Similar articles
-
Post-Transplantation Cyclophosphamide Uniquely Restrains Alloreactive CD4+ T-Cell Proliferation and Differentiation After Murine MHC-Haploidentical Hematopoietic Cell Transplantation.Front Immunol. 2022 Feb 15;13:796349. doi: 10.3389/fimmu.2022.796349. eCollection 2022. Front Immunol. 2022. PMID: 35242129 Free PMC article.
-
Mechanisms of Graft-versus-Host Disease Prevention by Post-transplantation Cyclophosphamide: An Evolving Understanding.Front Immunol. 2019 Nov 29;10:2668. doi: 10.3389/fimmu.2019.02668. eCollection 2019. Front Immunol. 2019. PMID: 31849930 Free PMC article. Review.
-
Post-transplantation cyclophosphamide prevents graft-versus-host disease by inducing alloreactive T cell dysfunction and suppression.J Clin Invest. 2019 Mar 26;129(6):2357-2373. doi: 10.1172/JCI124218. J Clin Invest. 2019. PMID: 30913039 Free PMC article.
-
Posttransplant cyclophosphamide contributes to the impairment of the graft-versus-leukemia effect and the amelioration of graft-versus-host disease with the suppression of alloreactive T cells in a murine stem cell transplant model.Exp Hematol. 2023 Jul;123:56-65. doi: 10.1016/j.exphem.2023.04.003. Epub 2023 Apr 23. Exp Hematol. 2023. PMID: 37098360
-
Systematic overview of HLA-matched allogeneic hematopoietic cell transplantation with post-transplantation cyclophosphamide.Int J Hematol. 2022 Oct;116(4):465-481. doi: 10.1007/s12185-022-03428-3. Epub 2022 Aug 5. Int J Hematol. 2022. PMID: 35930118
Cited by
-
Partially replacing cyclophosphamide with bendamustine in combination with cyclosporine A improves survival and reduces xenogeneic graft-versus-host-disease.Front Immunol. 2023 Jan 9;13:1045710. doi: 10.3389/fimmu.2022.1045710. eCollection 2022. Front Immunol. 2023. PMID: 36700195 Free PMC article.
-
Has the shortage of fludarabine altered the current paradigm of lymphodepletion in favor of bendamustine?Front Immunol. 2023 Nov 22;14:1329850. doi: 10.3389/fimmu.2023.1329850. eCollection 2023. Front Immunol. 2023. PMID: 38077398 Free PMC article. Review.
-
Comparable efficacy of oral bendamustine versus intravenous administration in treating hematologic malignancies.Cancer Chemother Pharmacol. 2024 Sep;94(3):361-372. doi: 10.1007/s00280-024-04688-y. Epub 2024 Jun 15. Cancer Chemother Pharmacol. 2024. PMID: 38878208
-
Impact of post-transplant cyclophosphamide with bendamustine on immune reconstitution in young patients undergoing T-cell replete haploidentical bone marrow transplantation: results from a phase Ia/Ib clinical trial.Front Immunol. 2025 Apr 9;16:1568862. doi: 10.3389/fimmu.2025.1568862. eCollection 2025. Front Immunol. 2025. PMID: 40270968 Free PMC article. Clinical Trial.
References
-
- Hadjis AD, Nunes NS, Khan SM, Fletcher RE, Pohl A, Venzon DJ, et al. . Post-Transplantation Cyclophosphamide Uniquely Restrains Alloreactive CD4+ T-Cell Proliferation and Differentiation After Murine MHC-Haploidentical Hematopoietic Cell Transplantation. Front Immunol (2022) 13:796349. doi: 10.3389/fimmu.2022.796349 - DOI - PMC - PubMed
-
- Routy B, Letendre C, Enot D, Chenard-Poirier M, Mehraj V, Seguin NC, et al. . The Influence of Gut-Decontamination Prophylactic Antibiotics on Acute Graft-Versus-Host Disease and Survival Following Allogeneic Hematopoietic Stem Cell Transplantation. Oncoimmunology (2017) 6(1):e1258506. doi: 10.1080/2162402X.2016.1258506 - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials